SCLC cell death activated by this combination is Noxa-dependent in certain cell lines, while in others it is due to the blocking of BCL-XL and subsequent release of BAK from BCL-XL and MCL-1 [46]. Here, BCL2L1 is linked to small cell lung carcinoma.